Management of sudden psychiatric disorders related to efavirenz.

Suppr

超能文献

作者信息

Peyriere H, Mauboussin J M, Rouanet I, Fabre J, Reynes J, Hillaire-Buys D

出版信息

AIDS. 2001 Jul 6;15(10):1323-4. doi: 10.1097/00002030-200107060-00021.

DOI:10.1097/00002030-200107060-00021

PMID:11426084

Abstract

摘要

相似文献

Management of sudden psychiatric disorders related to efavirenz.

AIDS. 2001 Jul 6;15(10):1323-4. doi: 10.1097/00002030-200107060-00021.

Neuropsychiatric effects of efavirenz: delayed onset.

Int J STD AIDS. 2005 Nov;16(11):769-70. doi: 10.1258/095646205774763261.

Efavirenz and retinal toxicity.

Eye (Lond). 2002 Jan;16(1):107. doi: 10.1038/sj.eye.6700038.

Efavirenz-induced psychosis.

AIDS. 2001 Sep 28;15(14):1911-2. doi: 10.1097/00002030-200109280-00033.

Efavirenz-induced catatonia.

AIDS. 2002 Sep 6;16(13):1841-2. doi: 10.1097/00002030-200209060-00024.

Efavirenz-induced photoallergic dermatitis in HIV.

AIDS. 2001 May 25;15(8):1085-6. doi: 10.1097/00002030-200105250-00029.

Hypersensitivity syndrome associated with efavirenz therapy.

Clin Infect Dis. 2000 Jan;30(1):227-8. doi: 10.1086/313629.

Psychiatric and neuropsychiatric manifestations of HIV infection.

J Int Assoc Physicians AIDS Care (Chic). 2003 Apr-Jun;2(2):88; author reply 89-90. doi: 10.1177/154510970300200206.

Higher efavirenz plasma levels correlate with development of insomnia.

J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):399-400. doi: 10.1097/00126334-200112010-00015.

Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz.

AIDS. 2001 Jul 27;15(11):1447-8. doi: 10.1097/00002030-200107270-00018.

引用本文的文献

Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.

J Neuroimmune Pharmacol. 2021 Mar;16(1):90-112. doi: 10.1007/s11481-019-09868-9. Epub 2019 Aug 6.

HIV and mental illness in Malawi and the neuropsychiatric sequelae of efavirenz.

Malawi Med J. 2018 Mar;30(1):40-45. doi: 10.4314/mmj.v30i1.9.

Antiretroviral treatment induced catatonia in 16-year-old boy.

J Pediatr Neurosci. 2014 Sep-Dec;9(3):283-5. doi: 10.4103/1817-1745.147598.

Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.

Ann Intern Med. 2014 Jul 1;161(1):1-10. doi: 10.7326/M14-0293.

Neuropsychiatric sequelae in an efavirenz treated patient with hepatitis B.

BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.07.2009.2061. Epub 2009 Nov 26.

Neuropsychiatric complications of antiretroviral therapy.

Drug Saf. 2006;29(10):865-74. doi: 10.2165/00002018-200629100-00004.

Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals.

Clin Pharmacokinet. 2005;44(8):849-61. doi: 10.2165/00003088-200544080-00006.

Practical guidelines to interpret plasma concentrations of antiretroviral drugs.

Clin Pharmacokinet. 2004;43(13):845-53. doi: 10.2165/00003088-200443130-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Management of sudden psychiatric disorders related to efavirenz.

AIDS. 2001 Jul 6;15(10):1323-4. doi: 10.1097/00002030-200107060-00021.

Neuropsychiatric effects of efavirenz: delayed onset.

Int J STD AIDS. 2005 Nov;16(11):769-70. doi: 10.1258/095646205774763261.

Efavirenz and retinal toxicity.

Eye (Lond). 2002 Jan;16(1):107. doi: 10.1038/sj.eye.6700038.

Efavirenz-induced psychosis.

AIDS. 2001 Sep 28;15(14):1911-2. doi: 10.1097/00002030-200109280-00033.

Efavirenz-induced catatonia.

AIDS. 2002 Sep 6;16(13):1841-2. doi: 10.1097/00002030-200209060-00024.

Efavirenz-induced photoallergic dermatitis in HIV.

AIDS. 2001 May 25;15(8):1085-6. doi: 10.1097/00002030-200105250-00029.

Hypersensitivity syndrome associated with efavirenz therapy.

Clin Infect Dis. 2000 Jan;30(1):227-8. doi: 10.1086/313629.

Psychiatric and neuropsychiatric manifestations of HIV infection.

J Int Assoc Physicians AIDS Care (Chic). 2003 Apr-Jun;2(2):88; author reply 89-90. doi: 10.1177/154510970300200206.

Higher efavirenz plasma levels correlate with development of insomnia.

J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):399-400. doi: 10.1097/00126334-200112010-00015.

Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz.

AIDS. 2001 Jul 27;15(11):1447-8. doi: 10.1097/00002030-200107270-00018.

引用本文的文献

Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.

J Neuroimmune Pharmacol. 2021 Mar;16(1):90-112. doi: 10.1007/s11481-019-09868-9. Epub 2019 Aug 6.

HIV and mental illness in Malawi and the neuropsychiatric sequelae of efavirenz.

Malawi Med J. 2018 Mar;30(1):40-45. doi: 10.4314/mmj.v30i1.9.

Antiretroviral treatment induced catatonia in 16-year-old boy.

J Pediatr Neurosci. 2014 Sep-Dec;9(3):283-5. doi: 10.4103/1817-1745.147598.

Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.

Ann Intern Med. 2014 Jul 1;161(1):1-10. doi: 10.7326/M14-0293.

Neuropsychiatric sequelae in an efavirenz treated patient with hepatitis B.

BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.07.2009.2061. Epub 2009 Nov 26.

Neuropsychiatric complications of antiretroviral therapy.

Drug Saf. 2006;29(10):865-74. doi: 10.2165/00002018-200629100-00004.

Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals.

Clin Pharmacokinet. 2005;44(8):849-61. doi: 10.2165/00003088-200544080-00006.

Practical guidelines to interpret plasma concentrations of antiretroviral drugs.

Clin Pharmacokinet. 2004;43(13):845-53. doi: 10.2165/00003088-200443130-00002.